1. Home
  2. KTF vs SMTI Comparison

KTF vs SMTI Comparison

Compare KTF & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DWS Municipal Income Trust

KTF

DWS Municipal Income Trust

BUY

Current Price

$8.04

Market Cap

361.2M

Sector

Finance

ML Signal

BUY

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$35.00

Market Cap

320.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTF
SMTI
Founded
1988
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.2M
320.2M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
KTF
SMTI
Price
$8.04
$35.00
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
★ $35.00
AVG Volume (30 Days)
★ 373.2K
166.9K
Earning Date
01-01-0001
11-11-2026
Dividend Yield
★ 3.54%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.39
N/A
Revenue
N/A
★ $15,586,976.00
Revenue This Year
N/A
$13.07
Revenue Next Year
N/A
$14.23
P/E Ratio
$20.77
★ N/A
Revenue Growth
N/A
★ 32.47
52 Week Low
$7.95
$16.05
52 Week High
$9.37
$35.34

Technical Indicators

Market Signals
Indicator
KTF
SMTI
Relative Strength Index (RSI) 25.77 62.38
Support Level N/A $33.99
Resistance Level $9.26 $35.34
Average True Range (ATR) 0.09 0.22
MACD -0.02 -0.16
Stochastic Oscillator 13.21 47.62

Price Performance

Historical Comparison
KTF
SMTI

About KTF DWS Municipal Income Trust

DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: